shouldiuse.io

Comparison

Research 360 by Motilal Oswal vs Screener.in

Research 360 by Motilal Oswal lands on Depends, and Screener.in lands on Worth it.

Research 360 by Motilal Oswal versus Screener.in
CompareResearch 360 by Motilal OswalScreener.in
VerdictDependsWorth it
Best forActive Indian equity tradersIndian retail investors
Who it's not forPassive index-fund investors . no need for trading ideasTraders needing real-time charts or execution . this is fundamentals-only
PrivacyNo known public vulnerabilities found in the sources reviewed.⁹No known public vulnerabilities found in the sources reviewed.11
Support qualityOnly self-published testimonials foundNo support evidence in reviewed sources
Public sentimentPublic reviews praise the app's consolidated stock data and beginner-friendly research, but most visible reviews appear on Motilal-affiliated pages.¹Investors across Reddit, LinkedIn, and Twitter threads consistently recommend it as the default free fundamentals tool for Indian stocks.13
Biggest gotchaPricing isn't published; expect plan details gated behind onboarding or a broker relationship³Pricing not disclosed in reviewed sources . confirm paid-plan limits before committing10

Pick Research 360 by Motilal Oswal when

  • Active Indian equity traders
  • Beginners wanting guided research
  • Motilal Oswal brokerage clients
  • IPO-focused investors

When Research 360 by Motilal Oswal is not a fit

  • Passive index-fund investors . no need for trading ideas
  • Non-India investors . this is India-market only
  • Buyers needing transparent pricing before committing
  • Anyone wanting independent reviews, not broker-affiliated ones

Pick Screener.in when

  • Indian retail investors
  • Fundamental-analysis beginners
  • Long-term stock pickers
  • DIY portfolio research

When Screener.in is not a fit

  • Traders needing real-time charts or execution . this is fundamentals-only
  • Investors in US or global stocks . India coverage only
  • Institutions wanting Bloomberg-grade data depth
  • Derivatives/F&O traders . no derivatives screening in evidence

Sources

  1. review
  2. official
  3. official
  4. official
  5. review
  6. review
  7. news
  8. news
  9. security
  10. official
  11. security
  12. review
  13. review
  14. review
  15. review
  16. Radar by Definedge Securitiesradar.definedgesecurities.com
    official